Drugs / CD34+ cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00074997 Background | Dec 2002 → Jan 2008 | — | Janssen-Cilag Pty Ltd | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00074997 ↗ |
| Modality | Cell therapy | “autologous CD34+ hematopoietic progenitor cells” NCT00074997 ↗ |